Capstone Investment Advisors
MRNA icon

Capstone Investment Advisors’s Moderna MRNA Stock Holding History

Capstone Investment Advisors’s Portfolio MRNA Stock Details MRNA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-5,755
Closed -$298K – 1823
2026
Q1 		$292K Buy
+5,755
New +$268K ﹤0.01% 1371
2025
Q4 		– Sell
-129,939
Closed -$3.53M – 1896
2025
Q3 		$3.36M Buy
129,939
+104,329
+407% +$2.91M 0.01% 592
2025
Q2 		$707K Sell
25,610
-16,463
-39% -$434K ﹤0.01% 984
2025
Q1 		$1.19M Sell
42,073
-9,074
-18% -$322K ﹤0.01% 832
2024
Q4 		$2.13M Sell
51,147
-47,062
-48% -$2.25M 0.01% 831
2024
Q3 		$6.56M Buy
98,209
+79,899
+436% +$7.34M 0.02% 397
2024
Q2 		$2.17M Buy
18,310
+7,370
+67% +$933K 0.01% 690
2024
Q1 		$1.17M Buy
10,940
+3,034
+38% +$306K ﹤0.01% 1057
2023
Q4 		$786K Sell
7,906
-46,956
-86% -$3.95M ﹤0.01% 1144
2023
Q3 		$5.67M Buy
54,862
+14,050
+34% +$1.57M 0.03% 391
2023
Q2 		$4.96M Buy
40,812
+20,978
+106% +$2.8M 0.02% 381
2023
Q1 		$3.05M Sell
19,834
-20,565
-51% -$3.39M 0.02% 479
2022
Q4 		$7.26M Sell
40,399
-5,199
-11% -$850K 0.05% 296
2022
Q3 		$5.39M Buy
45,598
+8,651
+23% +$1.31M 0.03% 384
2022
Q2 		$5.28M Sell
36,947
-21,294
-37% -$3.04M 0.03% 399
2022
Q1 		$10M Buy
58,241
+17,112
+42% +$2.88M 0.03% 465
2021
Q4 		$10.4M Buy
41,129
+33,658
+451% +$9.84M 0.02% 588
2021
Q3 		$2.88M Buy
+7,471
New +$2.76M 0.01% 1067
2020
Q4 		– Sell
-12,840
Closed -$1.3M – 1726
2020
Q3 		$908K Buy
+12,840
New +$895K ﹤0.01% 1041

Other funds holding MRNA

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
TP
Theleme Partners London, United Kingdom $1.68B AUM 19.9% 1-Year Est. Return

Capstone Investment Advisors's MRNA Position: Q2 2026 in Review

Capstone Investment Advisors sold out of Moderna (MRNA) in Q2 2026, closing a stake of 5,755 shares — an estimated $298K sold.

Capstone Investment Advisors first reported a position in MRNA in Q3 2020 and held it in 19 quarters. The position peaked at $10.4M in Q4 2021. 780 funds tracked by Wall St. Rank hold MRNA as of Q2 2026.

  • Capstone Investment Advisors reported no remaining Moderna position as of Q2 2026 after selling out during the quarter.
  • Capstone Investment Advisors sold 5,755 Moderna shares in Q2 2026, an estimated $298K.
  • Capstone Investment Advisors first reported a position in Moderna in Q3 2020 and held it in 19 quarters.
  • Capstone Investment Advisors's Moderna position peaked at $10.4M in Q4 2021.
  • 780 funds tracked by Wall St. Rank held Moderna as of Q2 2026.

Based on Capstone Investment Advisors's 13F filing for Q2 2026, filed 17 Aug 2026.